Source: Annual Congress 2005 - Atypical bacteria, fungal and parasitic infections of the lung
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Tokunaga, N. Takayanagi, K. Kurashima, Y. Sugita, M. Kanazawa (Kohnan, Moroyama, Japan). Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG). Eur Respir J 2005; 26: Suppl. 49, 2617

Member's Comments

No comment yet.

Related content which might interest you: Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma Source: Eur Respir J 2011; 37: 865-872 Year: 2011 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection Year: 2009 Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients Source: Eur Respir J 2001 Jan 01;19(4):743-755 Year: 2002 Caspofungin pulses for CPA (chronic pulmonary aspergillosis): A retrospective study Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Omalizumab and voriconazole in allergic broncopulmonary aspergillosis (A case series) Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Chronic pulmonary aspergillosis complicating sarcoidosis Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016 Year: 2017 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis Source: Eur Respir J 2006; 28: 352-357 Year: 2006 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Breakthrough invasive pulmonary aspergillosis (IPA) in patients receiving posaconazole prophylaxis (PPxis) Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis Source: Eur Respir J 2007; 30: Suppl. 51, 301s Year: 2007 Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide Source: Eur Respir J 2002; 20: 127-133 Year: 2002 PET‘s importance in chronic pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006